Jamaica scientist launches medical marijuana firm (Update)

by David Mcfadden

A prominent Jamaican scientist and entrepreneur is launching a company that aims to capitalize on medical marijuana, a growing global industry that he asserted Wednesday could be a boon for the island's chronically limping economy.

Henry Lowe, a researcher who specializes in medicinal chemistry and the chairman of an institute that develops therapeutic and cosmetic products from various plants in Jamaica, is calling his new venture Medicanja. It will focus on isolating medicinal compounds in the cannabis plant, known locally as "ganja," and Lowe said the research will not violate any local laws or international conventions.

Lowe said Jamaica could become a powerhouse in the nascent medical marijuana industry, health tourism and the development of innovative pot-derived items. Local scientists already have a history of creating marijuana-derived products, such as "Canasol," which helps relieve pressure in the eyes of glaucoma patients.

"This is a big opportunity for us," Lowe said in a phone interview.

Marijuana is pervasive on the Caribbean island despite being prohibited since 1913. It's long been used as a medicinal herb by Jamaican families and as a spiritual sacrament by Rastafarians. In 2001, a government-appointed commission said pot was "culturally entrenched" and recommended decriminalization, but the effort stalled.

Advocates for pot say it's time for Jamaica to give its moribund economy a boost by embracing cannabis-related ventures. With a growing number of U.S. states changing their marijuana laws, and voters in Washington and Colorado legalizing marijuana, the activists say Jamaica should decriminalize pot and stop worrying that might anger the U.S. The island has long been the Caribbean's biggest pot exporter to the U.S.

Influential politicians are increasingly taking up the idea. Health Minister Fenton Ferguson said last week that he is "fully on board" with medical marijuana, and the justice minister has said the Cabinet should be asked to consider changes to pot laws before the end of the year.

Some church leaders and lawmakers oppose decriminalization of even small amounts of marijuana, arguing the negative effects of the drug outweigh any benefits, especially for young people. But many of them say they have no problem with medical marijuana research.

5 /5 (1 vote)
add to favorites email to friend print save as pdf

Related Stories

US governors seek federal marijuana clearance

Dec 01, 2011

A pair of US governors have filed a petition asking the US federal government to allow wider use of medical marijuana by authorizing doctors to prescribe it and pharmacies to provide it.

Puerto Rico to debate medical use of marijuana

Sep 06, 2013

Legislators in Puerto Rico are preparing to debate a bill that would allow people to use marijuana for medicinal purposes in this conservative U.S. territory, officials said Thursday.

Recommended for you

Boxed warnings are common in novel therapeutics

Aug 19, 2014

(HealthDay)—Boxed warnings are common on recent drug approvals, and many occur years after approval, according to a research letter published online Aug. 15 in JAMA Internal Medicine.

AstraZeneca says DOJ closes probe into drug trial

Aug 19, 2014

British drugmaker AstraZeneca says the U.S. Department of Justice has closed its investigation into a clinical trial of the company's blood thinner Brilinta, and plans no further action.

Perampanel for epilepsy: Still no proof of added benefit

Aug 19, 2014

The drug perampanel (trade name Fycompa) has been approved since July 2012 as adjunctive ("add-on") therapy for adults and children aged 12 years and older with epileptic fits (seizures). In a new early benefit assessment ...

User comments